Avoro Capital Advisors LLC - 30 Sep 2025 SCHEDULE 13G/A Report for MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share (MLTX)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share
Symbol: MLTX
Shares outstanding: 63,492,063 shares
Disclosed Ownership: 2,000,000 shares
Ownership: 3.2%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 09:03:05 UTC
Date of event: 30 Sep 2025
Previous filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	3.2%	2,000,000	2,000,000	0	/s/ Scott Epstein	Scott Epstein, Chief Operating Officer & Chief Compliance Officer
Behzad Aghazadeh	3.2%	2,000,000	2,000,000	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually